P. Leavey

发表

Histopathological Diagnosis for Viable and Non-viable Tumor Prediction for Osteosarcoma Using Convolutional Neural Network

Ovidiu Daescu, Rashika Mishra, Patrick Leavey, 2017, ISBRA.

Convolutional Neural Network for Histopathological Analysis of Osteosarcoma

Ovidiu Daescu, Rashika Mishra, Patrick Leavey, 2017, J. Comput. Biol..

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

Lawrence H. Schwartz, Donald A. Berry, Janis M. Taube, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

KAI-1 Expression in Pediatric High-Grade Osteosarcoma

P. Leavey, R. Ashfaq, C. Timmons, 2006, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

ASCOT identifies key regulators of neuronal subtype-specific splicing

Brian S. Clark, B. Langmead, P. Leavey, 2020, Nature Communications.

Brief report: successful therapy of a patient with infantile generalized myofibromatosis.

A. Edwards, P. Leavey, A. Weinberg, 2002, Medical and pediatric oncology.

The American Society of Pediatric Hematology/Oncology workforce assessment: Part 2—Implications for fellowship training

P. Leavey, C. Dandoy, S. Badawy, 2018, Pediatric blood & cancer.

Control of neurogenic competence in mammalian hypothalamic tanycytes

Leighton H. Duncan, S. P. Brown, P. Leavey, 2020, bioRxiv.

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group

P. Leavey, N. Tarbell, M. Gebhardt, 2008, Pediatric blood & cancer.

Bone Scintigraphy in Osteosarcoma: A Single Institution Experience

P. Leavey, J. Powers, Carrye R. Cost, 2014, Journal of pediatric hematology/oncology.

Genetic loss of function of Ptbp1 does not induce glia-to-neuron conversion in retina

Dong Won Kim, P. Leavey, S. Blackshaw, 2022, Cell reports.

Lack of Prognostic Significance of Intratumoral Angiogenesis in Nonmetastatic Osteosarcoma

P. Leavey, J. Reisch, C. Timmons, 2001, Journal of pediatric hematology/oncology.

Cyclooxygenase-2 Expression Does Not Correlate With Outcome in Osteosarcoma or Rhabdomyosarcoma

P. Leavey, C. Timmons, T. Cripe, 2003, Journal of pediatric hematology/oncology.

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

C. Antonescu, B. Crompton, E. Álava, 2022, npj Precision Oncology.

Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility using scRNA-Seq and scATAC-Seq.

P. Leavey, S. Blackshaw, Clayton P. Santiago, 2021, Journal of visualized experiments : JoVE.

Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program.

Jasmin A. Tiro, P. Leavey, D. Gerber, 2022, Contemporary clinical trials.

Metachronous diagnosis of synovial sarcoma and papillary thyroid carcinoma in a child

P. Leavey, Anita Sengupta, Adeline Yang, 2021, Pediatric blood & cancer.

Functional characteristics of neutrophils collected and stored after administration of G–CSF

P. Leavey, D. Ambruso, G. Thurman, 2000, Transfusion.

In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro.

P. Leavey, C. Silliman, D. Elzi, 1998, Blood.

A 29-kDa Protein Associated with p67 phox Expresses Both Peroxiredoxin and Phospholipase A2 Activity and Enhances Superoxide Anion Production by a Cell-free System of NADPH Oxidase Activity*

P. Leavey, L. Rinckel, F. Kuypers, 2002, The Journal of Biological Chemistry.

Predictive Value of Interleukin-5 and Monocyte Chemotactic Protein-1 for Bacteremia in Children With Febrile Neutropenia

O. Ramilo, P. Leavey, N. Winick, 2012, Journal of pediatric hematology/oncology.

Effective removal of methotrexate by high-flux hemodialysis

P. Leavey, R. Quigley, G. Arbus, 2002, Pediatric Nephrology.

In Vivo Treatment With Granulocyte Colony-Stimulating Factor Does Not Delay Apoptosis in Human Neutrophils by Increasing the Expression of the Vacuolar Proton ATPase

P. Leavey, M. Ellison, J. Zimbelman, 2002, Journal of Investigative Medicine.

Evaluation for Bleeding Disorders in Suspected Child Abuse.

P. Leavey, S. Downs, E. Mendonça, 2018, Pediatrics.

Hoping Is Coping: A Guiding Theoretical Framework for Promoting Coping and Adjustment Following Pediatric Cancer Diagnosis.

S. Stewart, P. Leavey, J. Germann, 2015, Journal of pediatric psychology.

Viable and necrotic tumor assessment from whole slide images of osteosarcoma using machine-learning and deep-learning models

Ovidiu Daescu, Rashika Mishra, Patrick Leavey, 2019, PloS one.

Do pediatric hematology/oncology (PHO) fellows receive communication training?

P. Leavey, C. Bylund, Carma L. Bylund, 2014, Pediatric blood & cancer.

PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma

P. Leavey, D. Finkelstein, M. Hatley, 2018, Oncogene.

Osteogenic sarcoma and Rothmund Thomson syndrome

P. Leavey, P. Smith, R. Sneath, 2005, Journal of Cancer Research and Clinical Oncology.

Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

P. Leavey, J. Healey, M. Devidas, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

M. Sydes, P. Leavey, R. Goldsby, 2019, European journal of cancer.

The prevalence and use of antidepressant medication in pediatric cancer patients.

P. Leavey, Naveed Ahmad, A. Portteus, 2006, Journal of child and adolescent psychopharmacology.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

K. S. Hall, M. Sydes, P. Leavey, 2016, The Lancet. Oncology.

Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers

P. Leavey, N. LeBoeuf, A. Al-Ibraheemi, 2020, Clinical Cancer Research.

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

E. V. Van Allen, G. Ha, B. Crompton, 2018, British Journal of Cancer.

Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologies.

B. Faubert, R. Deberardinis, P. Leavey, 2021, Med.

Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity

P. Leavey, J. Rehg, D. Finkelstein, 2021, Nature Communications.

Ewing sarcoma: prognostic criteria, outcomes and future treatment

P. Leavey, A. Collier, 2008, Expert review of anticancer therapy.

PAX genes in childhood oncogenesis: developmental biology gone awry?

P. Leavey, R. L. Galindo, P. Mahajan, 2014, Oncogene.

Langerhans cell histiocytosis — a 31 year review

P. Leavey, F. Breatnach, M. Varughese, 1991, Irish journal of medical science.

Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy

Ka Yaw Teo, O. Daescu, P. Leavey, 2022, PloS one.

Prolonged response to sorafenib in a patient with refractory metastatic osteosarcoma and a somatic PDGFRA D846V mutation

P. Leavey, Amy L. Walz, Amy E Armstrong, 2018, Pediatric blood & cancer.

Fractionated cyclophosphamide and etoposide for children with advanced or refractory solid tumors: a phase II window study.

P. Leavey, N. Winick, E. Mantadakis, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement.

P. Leavey, T. McCavit, Susan Wu, 2015, Journal of pediatric hematology/oncology.

Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib

P. Leavey, D. Rakheja, M. Rosenzweig, 2019, Cold Spring Harbor molecular case studies.

IL-8 Predicts Pediatric Oncology Patients With Febrile Neutropenia at Low Risk for Bacteremia

P. Leavey, D. Leonard, C. Cost, 2013, Journal of pediatric hematology/oncology.

Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney

D. Wheeler, Pavel Sumazin, H. Doddapaneni, 2015, Nature Communications.

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report

P. Leavey, R. Randall, D. Hawkins, 2021, Journal of Clinical Oncology.

Humanism and professionalism education for pediatric hematology‐oncology fellows: A model for pediatric subspecialty training

P. Leavey, D. Adams, Amulya A Nageswara Rao, 2015, Pediatric blood & cancer.

Deep learning of rhabdomyosarcoma pathology images for classification and survival outcome prediction.

O. Daescu, P. Leavey, Shidan Wang, 2022, The American journal of pathology.

Extracorporeal membrane oxygenation (ECMO) initiation without intubation in two children with mediastinal malignancy

P. Leavey, Nilda M. Garcia, C. Quinn, 2007, Pediatric blood & cancer.

The Epidermal Growth Factor Receptor HER2 Is Not a Major Therapeutic Target in Ewing Sarcoma

A. Maitra, P. Leavey, R. Ashfaq, 2003, Journal of pediatric hematology/oncology.

Skip metastasis in osteosarcoma.

P. Leavey, T. Booth, G. Maale, 2003, Journal of pediatric hematology/oncology.

Intra-operative radiation therapy in pediatric neuroblastoma.

P. Leavey, L. McNeely, L. Odom, 1997, Medical and pediatric oncology.

Ptbp1 deletion does not induce glia-to-neuron conversion in adult mouse retina and brain

P. Leavey, S. Blackshaw, Sika Zheng, 2021, bioRxiv.

Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

G. Ha, B. Crompton, K. Stegmaier, 2019, British Journal of Cancer.

Depression and anxiety (DA) in children within one year of a cancer diagnosis.

S. Stewart, P. Leavey, J. Germann, 2013 .

Computer Aided Image Segmentation and Classification for Viable and Non-Viable Tumor Identification in Osteosarcoma

Ovidiu Daescu, Bogdan Armaselu, Rashika Mishra, 2017, PSB.

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

E. V. Van Allen, G. Ha, B. Crompton, 2018, British Journal of Cancer.

VARIABILITY IN DOSE INTENSITY OF HIGH-DOSE METHOTREXATE FOR NONMETASTATIC OSTEOSARCOMA

P. Leavey, E. Mantadakis, G. Maale, 2002, Pediatric hematology and oncology.

Signs and Symptoms

P. Leavey, Andrew A. Martin, 2015 .

Cell-specific regulation of gene expression using splicing-dependent frameshifting

Kristina J. Nielsen, Leighton H. Duncan, B. Langmead, 2022, bioRxiv.

Biomarker development in osteosarcoma—Is there no longer any utility to tumor necrosis?

P. Leavey, 2016, Pediatric blood & cancer.

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence

P. Leavey, Zhengjia Chen, M. Bernstein, 2007 .

Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors

P. Leavey, N. Winick, G. Tomlinson, 2004, Pediatric blood & cancer.

Important principles in Ewing sarcoma treatment

P. Leavey, 2014, Pediatric blood & cancer.

K. S. Hall, M. Sydes, P. Leavey, 2016, The Lancet. Oncology.

Cedar Trial in Progress: A First in Human, Phase 1/2 Study of the Correction of a Single Nucleotide Mutation in Autologous HSCs (GPH101) to Convert HbS to HbA for Treating Severe SCD

P. Leavey, J. Dipersio, M. Porteus, 2021, Blood.

Control of neurogenic competence in mammalian hypothalamic tanycytes

Leighton H. Duncan, S. P. Brown, P. Leavey, 2021, Science Advances.

Graduate medical education changes: Yes we can or enough already?

P. Leavey, R. Jubran, 2012, Pediatric blood & cancer.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

M. Sydes, P. Leavey, R. Goldsby, 2019, European journal of cancer.

Machine Learning for Rhabdomyosarcoma Whole Slide Images Sub-type Classification

O. Daescu, P. Leavey, E. Rudzinski, 2023, PETRA.

Rhabdomyosarcoma Histology Classification using Ensemble of Deep Learning Networks

Ovidiu Daescu, Patrick Leavey, Saloni Agarwal, 2020, BCB.

Use of machine learning in bone cancers

Ovidiu Daescu, Patrick J. Leavey, O. Daescu, 2022, Bone Cancer.